Vnitr Lek 2025, 71(8):E22-E27

Suspected pellagra in a patient treated with azathioprine for Crohn's disease

Pavel Polák1, Michal Řiháček1, 2, Andrea Wagnerová2, 3, Alexandr Trunečka4, Petra Adamczyk4, Dalibor Váhala5
1 Hematologicko-transfúzní oddělení, Nemocnice AGEL Prostějov
2 AGEL Transfúzní služba, a.s.
3 Oddělení laboratorní medicíny, Nemocnice AGEL Prostějov
4 Interní oddělení, Nemocnice AGEL Prostějov
5 Laboratoře AGEL, a.s., Nový Jičín

Pellagra is a disease due to nutritional deficiency of niacin (vitamin B3). The main causes include nutritionally poor diet or impaired intestinal absorbtion. Other risk factors represent alcohol abuse, idiopathic bowel disease and immunosuppressive and antituberculotic treatment. Dermatitis, diarrhoea and dementia (3D) are characteristical clinical signs, untreated disease may lead to the death. The diagnosis is based on typical clinical signs which subside quickly after niacin supplementation. The authors present a clinical case of a patient with Crohn´s disease treated with azathioprine, who was acutely hospitalized for community-onset pneumonia, pancytopenia and symetrical sharply bordered maculous erythematous limb exanthema - clinically suspected of pellagra. The exanthema subsided completely within a week of parenteral niacin supplementation. Bone marrow examination led to the diagnosis of myelodysplastic neoplasia with low-blasts (MDS-LB). Niacin deficiency may have potentiated genotoxic effects of azathioprine. The patient was referred to the specialized hematooncological center.

Keywords: azathioprine, Crohn's disease, myelodysplastic syndrome, pellagra.

Accepted: November 26, 2025; Published: December 15, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Polák P, Řiháček M, Wagnerová A, Trunečka A, Adamczyk P, Váhala D. Suspected pellagra in a patient treated with azathioprine for Crohn's disease. Vnitr Lek. 2025;71(8):E22-27.
Download citation

References

  1. Hałubiec P, Leończyk M, Staszewski F, et al. Pathophysiology and clinical management of pellagra - a review. Folia Med Cracov. 2021; 61:125-137. doi: 10.24425/fmc.2021.138956. Go to original source... Go to PubMed...
  2. Prabhu D, Dawe RS, Mponda K. Pellagra a review exploring causes and mechanisms, including isoniazid- induced pellagra. Photodermatol Photoimmunol Photomed. 2021; 37:99-104. doi: 10.1111/phpp.12659. Go to original source... Go to PubMed...
  3. Rivadeneira A, Moyer P, Salciccioli JD. Pellagra in the USA: unusual manifestations of a rare entity. BMJ Case Rep. 2019; 12:e230972. doi:10.113/bcr-2019-230972. Go to original source...
  4. Mugabe VA, Mahumane A, Baltazar CS, et al. Cyclone Idai as a trigger for pellagra outbreak in Nhamatanda, Mozambique: A case control study. Am J Trop Med Hyg. 2021; 104(6):2233-2237. doi:10.4269/ajtmh.20-1321. Go to original source... Go to PubMed...
  5. Portale S, Sculati M, Stanford FC, et al. Pellagra and anorexia nervosa: a case report. Eat Weight Disord. 2020; 25(5):1493-1496. doi:10.1007/s40519-019-00781-x. Go to original source... Go to PubMed...
  6. Madhyastha SP, Shetty GV, Shetty VM, et al. The classic pellagra dermatitis. BMJ Case Rep. 2020; 13:e239741. doi:10.1136/bcr-2020-239741. Go to original source... Go to PubMed...
  7. Tew JC, Harrington L, Elsayed H, et al. Pellagra as a differential diagnosis in the confused patient on the acute medical unit. BMC Case Rep. 2022; 15:e249405. doi:10.1136/bcr-2022-249405. Go to original source... Go to PubMed...
  8. Wang J, Yu J, Huang X. Pellagra and peripheral neuropathy secondary to tuberculosis treatment. QJM: An International Journal of Medicine. 2023; 696-698. https://doi.org/10.1093/qjmed/hcad077. Go to original source... Go to PubMed...
  9. Filippi J, AI-Jaouni R, Wiroth JB, et al. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis. 2006; 12(3):185-191. doi: 10.1097/01.MIB.0000206541.15963.c3.PMID: 16534419. Go to original source...
  10. Hui R Ch-Y, Kuo K-L, Yang T-W. A rare skin complication associated with Crohn's disease. Dermatol Online J. 2021; 160(3):669-670. doi: 10.1053/j.gastro.2020. 09. 047 Go to original source...
  11. Dastychová E. Pelagra jako důsledek parciální resekce žaludku a chronického ethylismu. Prakt Lék. 1986; 66(17):634-635.
  12. Daniš M, Turček M. Pelarga jako komplikácia nadužívania alkohólu. Alkoholismus a drogové závislosti. 2017; 52(4):183-192.
  13. Crouwel F, Buiter HJC, de Boer NK. The thiopurine tale: an unexpected journey. J Crohn's Colitis. 2022; 16:1177-1183. https://doi.org/10.1093/ecco-jcc/jjac004 Go to original source... Go to PubMed...
  14. Souhrn údajů o přípravku Imasup 50 mg. Sp. zn. sukls34300/2025. Available from: https://prehledy.sukl.cz/prehled_leciv.html#/leciva/0249258.
  15. Abtahi-Naeini B, Rajabi P, Dehghani S. Azathioprine-induced pellagra in a child with autoimmune hepatitis: a case report and literature review. Clin Case Rep. 2021; 9:e04975. doi: 10.1002/ccr3.4975. Go to original source... Go to PubMed...
  16. Wroński K, Holecki MT, Boguszewska N, et al. Bone marrow aplasia and neutropenic fever following azathioprine dose escalation in a TPMT-deficient patient with Crohn's disease and psoriatic arthritis - a CARE-compliant case. Clin Pract. 2025; 15(114):1-9. https://doi.org/10.3390/clinpract15060114. Go to original source... Go to PubMed...
  17. De Boer NKH, Mulder CJJ, van Bodegraven AA. Myelotoxicity and hepatotoxicity during azathioprine therapy. Neth J Med. 2005; 63(11):444-446.
  18. Dickson AL, Daniel LL, Zanussi J, et al. TPMT and NUDT15 variants predict discontinuation of azathioprine for myelotoxicity in patients with inflammatory disease: real-world clinical results. Clin Pharmacol Ther. 2022; 111(1):263-271. doi:10.1002/cpt.2428. Go to original source... Go to PubMed...
  19. Tanaka Y, Saito Y. Importance of NUDT15 polymorphisms in thiopurine treatments. J Pers Med. 2021; 11(778):1-10. doi:10.330/jpm11080778. Go to original source...
  20. Hessels AC, Sanders JSF, van de Ven AAJM, et al. Azathioprine hypersensitivity syndrome in a cohort of antineutrophil cytoplasmic antibody-associated vasculitis patients. J Allergy Clin Immunol Pract. 2019; 7(3):1004-1009. doi:1.1016/j.jaip.2018. 10. 018. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.